Stereotaxis Inc (STXS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Stereotaxis Inc (STXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3384
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Stereotaxis Inc (Stereotaxis) designs, manufactures and markets robotic systems and instruments for electrophysiologists for the treatment of cardiac arrhythmias. Its flagship product, Epoch solution is an advanced remote robotic navigation system for use in interventional lab for the treatment of arrhythmias and coronary artery disease. The Epoch solution consists of Niobe ES robotic magnetic navigation system, Odyssey information management solution and Vdrive robotic navigation system. It also offers maintenance and support services for its integrated products. The company markets its products and services through direct sales force and through strategic alliances with other companies in the US, Europe and other parts of the world. Stereotaxis is headquartered in St. Louis, Missouri, the US.

Stereotaxis Inc (STXS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stereotaxis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Stereotaxis Inc, Medical Devices Deals, 2012 to YTD 2018 9
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 11
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 12
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 13
Stereotaxis Completes Private Placement Of Shares For US$10 Million 14
Stereotaxis Inc – Key Competitors 15
Stereotaxis Inc – Key Employees 16
Stereotaxis Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Financial Announcements 18
Aug 07, 2018: Stereotaxis reports 2018 second quarter financial results 18
Mar 06, 2018: Stereotaxis Reports 2017 Fourth Quarter And Full Year Financial Results 20
Jan 08, 2018: Stereotaxis Reports Preliminary Fourth Quarter 2017 Revenue Results 22
Nov 09, 2017: Stereotaxis Reports Third Quarter 2017 Financial Results 23
Aug 10, 2017: Stereotaxis Reports Second Quarter 2017 Financial Results 25
May 08, 2017: Stereotaxis Reports 2017 First Quarter Financial Results 26
Corporate Communications 27
Jun 04, 2018: Stereotaxis Announces Changes to its Board of Directors 27
Feb 06, 2017: Stereotaxis Announces Management Transition and 2016 Financial Results 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Stereotaxis Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stereotaxis Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stereotaxis Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Stereotaxis Inc, Medical Devices Deals, 2012 to YTD 2018 9
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Stereotaxis Announces Public Offering of Shares for Up To USD18 Million 11
Stereotaxis Completes Rights Offering Of Shares For US$10.2 Million 12
Stereotaxis Files Registration Statement For Public Offering Of Securities For Up To US$75 Million 13
Stereotaxis Completes Private Placement Of Shares For US$10 Million 14
Stereotaxis Inc, Key Competitors 15
Stereotaxis Inc, Key Employees 16
Stereotaxis Inc, Other Locations 17
Stereotaxis Inc, Subsidiaries 17

List of Figures
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Stereotaxis Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Stereotaxis Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Stereotaxis Inc (STXS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Swiss AviationSoftware Ltd.:企業の戦略的SWOT分析
    Swiss AviationSoftware Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • AmerisourceBergen Corporation:企業の戦略・SWOT・財務分析
    AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report Summary AmerisourceBergen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Sinopec Oilfield Service Corp (600871):企業の財務・戦略的SWOT分析
    Sinopec Oilfield Service Corp (600871) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Yungjin Pharm Co Ltd (003520):製薬・医療:M&Aディール及び事業提携情報
    Summary Yungjin Pharm Co Ltd (Yungjin), a subsidiary of KT&G Corp is a pharmaceutical company that develops, manufactures and distributes active pharmaceutical ingredients, formulations and tonic drinks. The company provides API products such as cephalosporins and other general products. It also off …
  • SKF AB:企業の戦略・SWOT・財務分析
    SKF AB - Strategy, SWOT and Corporate Finance Report Summary SKF AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • TransMontaigne Partners LP (TLP):企業の財務・戦略的SWOT分析
    Summary TransMontaigne Partners LP (TLP), a subsidiary of TransMontaigne GP LLC is an energy infrastructure service provider that offers integrated terminaling, transportation, and storage services. The company distributes and transports crude oil, chemicals, petroleum products, fertilizers, and oth …
  • B. Braun Melsungen AG:企業の戦略的SWOT分析
    B. Braun Melsungen AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • PT Medco Energi Internasional Tbk (MEDC):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Medco Energi Internasional Tbk (MedcoEnergi), a subsidiary of Encore Energy Pte. Ltd., is an integrated energy company. It explores for and develops oil and gas fields. The company provides energy related services such as power production, engineering procurement and construction (EPC), o …
  • MITIE Group plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ricoh Leasing Company, Ltd.:企業の戦略・SWOT・財務情報
    Ricoh Leasing Company, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ricoh Leasing Company, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • LivePerson Inc (LPSN):企業の財務・戦略的SWOT分析
    LivePerson Inc (LPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Banco Bilbao Vizcaya Argentaria Colombia SA:企業の戦略・SWOT・財務分析
    Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Haci Omer Sabanci Holding A.S. (SAHOL)-エネルギー分野:企業M&A・提携分析
    Summary Haci Omer Sabanci Holding A.S. (Sabanci) is an industrial and financial conglomerate. The company carries out banking, insurance, energy, retail, cement, insurance, automotive, tire and tire reinforcement materials businesses. The company has partnerships with various multinational business …
  • Medivir AB:企業のM&A・事業提携・投資動向
    Medivir AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medivir AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • CSX Corporation, Inc.:戦略・SWOT・企業財務分析
    CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report Summary CSX Corporation, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Hayleys PLC (HAYL.N0000):企業の財務・戦略的SWOT分析
    Summary Hayleys plc (Hayleys) is a diversified company that offers consumer services. The company’s products include purification products, textiles and construction materials, among others. It offers services such as treasury unit, strategic business development unit, corporate communications, corp …
  • Bechtel Power Corporation:企業の戦略的SWOT分析
    Bechtel Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • The Procter & Gamble Co:戦略・SWOT・企業財務分析
    The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report Summary The Procter & Gamble Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Bill Peach Group Limited:企業の戦略・SWOT・財務情報
    Bill Peach Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bill Peach Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Petroleos de Venezuela SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleos de Venezuela SA (PDVSA) is a state-owned oil and gas company. It plans, coordinates, supervises, and controls the activities in the entire oil and gas value chain. The company explores for and develops oil and other hydrocarbons; refines, trades, and supplies that in domestic and o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆